Search
for
Sort by
Research 511–540 of 1000+
- Finasteride-related Leydig cell tumour: report of a case and literature review
- Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial
- Ovarian Leydig cell tumor and postmenopausal hirsutism with signs of virilisation
- ADRENAL ONCOCYTOMA IN CHILDREN – case report
- Hypertrichosis lanuginosa acquisita following cytotoxic chemotherapy
- Caution with Hair Dye: Foreign Body Skull Erosive Granuloma from Exogenous Hair Pigmentation
- Triple-Negative Sjogren’s Syndrome and Recurrent Pneumothorax: An Uncommon Presentation of Autoimmune Disease
- Eosinophilic Pleural Effusion Due to Topical Minoxidil Use
- Predictors of Scalp Hair Thinning in Women with Polycystic Ovary Syndrome
- Case 33-2015
- Hair transplantation: A review and technique presentation
- Long-term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-year Results from the ALLEGRO-LT Phase 3, Open-label Study
- A rare case of poorly-differentiated endometrial carcinoma in a female-to-male transgender man on testosterone therapy
- Clinical Utility of GnRH Analogues in Female Androgen Excess: Highlighting Diagnostic and Therapeutic Applications
- Postmenopausal Ovarian Hyperthecosis Associated with Rapid Testosterone Excess
- Integrating multi-omics analyses of Nonomuraea dietziae to reveal the role of soybean oil in [(4′-OH)MeLeu]4-CsA overproduction
- A comparison between the preview long hair technique and the classic hair transplant technique
- The Case of the Elusive Androgen
- 5-Alpha-reductase deficiency in a Saudi "girl"
- Virilization beyond menopause: an uncommon ovarian tumor in an elderly patient with multimodality imaging and pathologic correlation
- Fibroblast depletion reveals mammalian epithelial resilience across neonatal and adult stages
- Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents with Alopecia Areata: 3-Year Results from the ALLEGRO Phase 2b/3 and ALLEGRO-LT Phase 3 Clinical Studies
- Responses to Tetanus and Meningococcal Vaccines in Patients with Alopecia Areata Treated with Ritlecitinib
- Multifocal Malignant Proliferating Trichilemmal Tumour: A Diagnostic Imitator Beyond the Scalp
- A unique presentation of trichofolliculoma in amniotic band syndrome
- Efficacy, Safety, and Tolerability of Upadacitinib in Adults and Adolescents With Severe Alopecia Areata: Results From the Randomized, Placebo-Controlled, Double-Blind Phase 3 Program (UP-AA)
- Baricitinib Provides Higher Efficacy in Adolescents Relative to Adults With Alopecia Areata Despite More Severe Disease at Baseline: 36-Week Outcomes From BRAVE-AA Trials
- Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata
- <i>De Novo</i> Design of Anti-Aging Peptides
- EFFECT OF JALAUKAVACHARANA IN KHALITYA (HAIRFALL): A CASE REPORT